1. < Home

Randomized clinical trial

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial

Jagannathan P, Chew KW, Giganti MJ, Hughes MD, Moser C, Main MJ, Monk PD, Javan AC, Li JZ, Fletcher CV, McCarthy C, Wohl DA, Daar[...]

By sjmartinez • October 19, 2023
Design and methods of a randomized trial testing advancing care for COPD in people living with HIV by implementing evidence-based management through proactive E-consults (ACHIEVE)

Ives J, Bagchi S, Soo S, Barrow C, Akgün KM, Erlandson KM, Goetz M, Griffith M, Gross R, Hulgan T, Moanna A, Soo Hoo GW,[...]

By sjmartinez • July 23, 2023
Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial

Zheng X, Gui X, Yao L, Ma J, He Y, Lou H, Gu J, Ying R, Chen L, Sun Q, Liu Y, Ho CM, Lee[...]

By sjmartinez • March 7, 2023
Evaluation of behavioral economic strategies to raise influenza vaccination rates across a health system: Results from a randomized clinical trial

Szilagyi PG, Casillas A, Duru OK, Ong MK, Vangala S, Tseng CH, Albertin C, Humiston SG, Ross MK, Friedman SR, Evans S, Sloyan M, Bogard[...]

By sjmartinez • March 5, 2023
Evaluation of Heart Failure Admission as a Surrogate for Mortality in Randomized Clinical Trials: A Meta-Analysis

Miyamoto Y, Kiyohara Y, Kohsaka S, Iwagami M, Tsugawa Y, Briasoulis A, Kuno T. Evaluation of Heart Failure Admission as a Surrogate for Mortality in[...]

By sjmartinez • February 18, 2023
A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis

Tayek JA, Stolz AA, Nguyen DV, Fleischman MW, Donovan JA, Alcorn JM, Chao DC, Asghar A, Morgan TR; Southern California Alcoholic Hepatitis (SCAH) Consortium. A[...]

By sjmartinez • October 22, 2022